Met Primary Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Met Primary Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Met Primary Endpoints Today - Breaking & Trending Today

FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors

Published: April 23, 2024

This approval makes lutetium Lu177 the first therapy to be approved for the treatment of gastroenteropancreatic neuroendocrine tumors in pediatric patients.

Source: pharmacytimes.com

Related Topics:

United StatesTheodore LaetschTina DeignanDevelopmental Therapeutics ProgramOlivier Le MoalEvaluate SafetyAdolescent Patients WithAdvanced AcceleratorTherapeutic Area HeadMet Primary EndpointsProgression Free SurvivalGastroenteropancreatic Neuroendocrine